ACTRN12621001608853
Recruiting
未知
Characterising prostate cancer patients undergoing androgen deprivation therapy: Is there a group of men more at risk of cognitive changes? A Cross-sectional Study
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Prostate Cancer
- Sponsor
- Macquarie University
- Enrollment
- 150
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Men aged 18 or older, who are able to read and speak English sufficiently well to respond to written questions and provide consent and have access to an electronic device will be included for the study. There will be three groups of participants:
- •i) Men diagnosed with prostate cancer, who are currently undergoing hormonal treatments (androgen deprivation therapy);
- •ii) Men diagnosed with prostate cancer, who have are on ‘watchful waiting’;
- •iii) Age\-matched men without a prostate cancer diagnosis.
Exclusion Criteria
- •Receiving a diagnosis of dementia prior to commencing treatment for prostate cancer.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 2
A continence promotion intervention involving a pelvic floor muscle rehabilitation exercise program to reduce lower urinary tract, lower bowel symptoms and erectile dysfunction in men receiving radiation therapy with or without androgen deprivation therapy (ADT): A Pilot StudyProstate Cancer TreatmentLower Urinary Tract sequelae to radiation therapy with or without androgen deprivation therapyLower Bowel Dysfunction as sequelae to radiation therapy with or without androgen deprivation therapyErectile Dysfunction as sequelae to radiation therapy with or without androgen deprivation therapyCancer - ProstatePhysical Medicine / Rehabilitation - PhysiotherapyRenal and Urogenital - Other renal and urogenital disordersACTRN12612000527864niversity of Newcastle40
Completed
Phase 1
Phase 0 Trial of Gallium-68 tris-hydroxypyridinone prostate specific membrane antigen (Ga-68 THP-PSMA) positron emission tomography (PET) scanning for prostate cancerprostate cancerCancer - ProstateACTRN12615001324505Peter MacCallum Cancer Centre14
Recruiting
Not Applicable
The safety and efficacy of Irreversible Electroporation for the ablation of prostate cancer assessed by procedural related side effects and post prostatectomy histology: A pilot studyProstate cancerCancer - ProstateACTRN12612000523808Flack Trustees6
Completed
Not Applicable
Patient involvement in prostate cancer treatment decisionsProstate cancerCancerISRCTN97145188Dutch Cancer Society (The Netherlands)300
Completed
Not Applicable
The Body concept of prostate carcinoma patientsC61Malignant neoplasm of prostateDRKS00003319Martin-Luther-Universität Halle WittenbergInstitut für Gesundheits- und Pflegewissenschaft339